432 related articles for article (PubMed ID: 26406957)
1. Significance of combined tests of serum golgi glycoprotein 73 and other biomarkers in diagnosis of small primary hepatocellular carcinoma.
Zhao Y; Wang M; Cui C; Zhang L; Liao F; Li H; Wu X
Cancer Biomark; 2015; 15(5):677-83. PubMed ID: 26406957
[TBL] [Abstract][Full Text] [Related]
2. A study of diagnostic value of golgi protein GP73 and its genetic assay in primary hepatic carcinoma.
Shi Y; Chen J; Li L; Sun Z; Zen L; Xu S; Zhang Y; Zhang L
Technol Cancer Res Treat; 2011 Jun; 10(3):287-94. PubMed ID: 21517136
[TBL] [Abstract][Full Text] [Related]
3. [Significance of serum golgi protein 73 (GP73), alpha-fetoprotein (AFP) and lectin-reactive alpha-fetoprotein (AFP-L3) expresssion in primary hepatic carcinoma].
Xu WF; Fei YM; Zhou JK; Shen HJ; Chen XF; Lv QQ; Ding YY
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2011 Aug; 25(4):286-8. PubMed ID: 22097609
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic value of serum Golgi protein 73 for HBV-related primary hepatic carcinoma.
Gao G; Dong F; Xu X; Hu A; Hu Y
Int J Clin Exp Pathol; 2015; 8(9):11379-85. PubMed ID: 26617863
[TBL] [Abstract][Full Text] [Related]
5. [Diagnosis value of combined detection of serum golgi protein 73, desgamma carboxy prothrombin and α-fetoprotein in primary hepatic carcinoma].
Huo Q; Zheng Z; Liu J; Li C; Hu C
Zhonghua Yi Xue Za Zhi; 2015 Mar; 95(10):757-60. PubMed ID: 26080848
[TBL] [Abstract][Full Text] [Related]
6. Golgi protein 73, not Glypican-3, may be a tumor marker complementary to α-Fetoprotein for hepatocellular carcinoma diagnosis.
Wang Y; Yang H; Xu H; Lu X; Sang X; Zhong S; Huang J; Mao Y
J Gastroenterol Hepatol; 2014 Mar; 29(3):597-602. PubMed ID: 24236824
[TBL] [Abstract][Full Text] [Related]
7. Clinical utility of simultaneous measurement of serum high-sensitivity des-gamma-carboxy prothrombin and Lens culinaris agglutinin A-reactive alpha-fetoprotein in patients with small hepatocellular carcinoma.
Sassa T; Kumada T; Nakano S; Uematsu T
Eur J Gastroenterol Hepatol; 1999 Dec; 11(12):1387-92. PubMed ID: 10654799
[TBL] [Abstract][Full Text] [Related]
8. Clinical Significance of Preoperative Hepatocellular Carcinoma With High
Yamao T; Yamashita YI; Imai K; Umezaki N; Tsukamoto M; Kitano Y; Arima K; Miyata T; Nakagawa S; Okabe H; Hayashi H; Chikamoto A; Ishiko T; Baba H
Anticancer Res; 2019 Feb; 39(2):883-889. PubMed ID: 30711971
[TBL] [Abstract][Full Text] [Related]
9. Elevated alpha-fetoprotein: differential diagnosis - hepatocellular carcinoma and other disorders.
Wong RJ; Ahmed A; Gish RG
Clin Liver Dis; 2015 May; 19(2):309-23. PubMed ID: 25921665
[TBL] [Abstract][Full Text] [Related]
10. Sequential fluctuation pattern of serum des-gamma-carboxy prothrombin levels detected by high-sensitive electrochemiluminescence system as an early predictive marker for hepatocellular carcinoma in patients with cirrhosis.
Shimizu A; Shiraki K; Ito T; Sugimoto K; Sakai T; Ohmori S; Murata K; Takase K; Tameda Y; Nakano T
Int J Mol Med; 2002 Mar; 9(3):245-50. PubMed ID: 11836630
[TBL] [Abstract][Full Text] [Related]
11. Analysis of serum α-fetoprotein-L3% and des-γ carboxyprothrombin markers in cases with misleading hepatocellular carcinoma total α-fetoprotein levels.
Hadziyannis E; Sialevris K; Georgiou A; Koskinas J
Oncol Rep; 2013 Feb; 29(2):835-9. PubMed ID: 23174906
[TBL] [Abstract][Full Text] [Related]
12. The diagnostic value of PIVKA-II, AFP, AFP-L3, CEA, and their combinations in primary and metastatic hepatocellular carcinoma.
Qi F; Zhou A; Yan L; Yuan X; Wang D; Chang R; Zhang Y; Shi F; Han X; Hou J; Wei L; Zhang X
J Clin Lab Anal; 2020 May; 34(5):e23158. PubMed ID: 31821607
[TBL] [Abstract][Full Text] [Related]
13. [Expression profiles and differential diagnostic value of serum Golgi protein-73 in patients with liver cirrhosis and primary hepatic carcinoma].
Yang Y; Xiao L; Mao R; Zhang H; Wen H; Zhao HR; He FP; Zhang YF; Bao YX
Zhonghua Gan Zang Bing Za Zhi; 2012 Dec; 20(12):920-4. PubMed ID: 23522254
[TBL] [Abstract][Full Text] [Related]
14. Novel Lens culinaris agglutinin-reactive fraction of α-fetoprotein: a biomarker of hepatocellular carcinoma recurrence in patients with low α-fetoprotein concentrations.
Morimoto M; Numata K; Nozaki A; Kondo M; Moriya S; Taguri M; Morita S; Konno M; Sugo A; Miyajima E; Maeda S; Tanaka K
Int J Clin Oncol; 2012 Aug; 17(4):373-9. PubMed ID: 21847534
[TBL] [Abstract][Full Text] [Related]
15. Combined use of AFP, PIVKA-II, and AFP-L3 as tumor markers enhances diagnostic accuracy for hepatocellular carcinoma in cirrhotic patients.
Lim TS; Kim DY; Han KH; Kim HS; Shin SH; Jung KS; Kim BK; Kim SU; Park JY; Ahn SH
Scand J Gastroenterol; 2016 Mar; 51(3):344-53. PubMed ID: 26340708
[TBL] [Abstract][Full Text] [Related]
16. Sublingual vein parameters, AFP, AFP-L3, and GP73 in patients with hepatocellular carcinoma.
Zhao J; Guo LY; Yang JM; Jia JW
Genet Mol Res; 2015 Jun; 14(2):7062-7. PubMed ID: 26125916
[TBL] [Abstract][Full Text] [Related]
17. AFP, AFP-L3, DCP, and GP73 as markers for monitoring treatment response and recurrence and as surrogate markers of clinicopathological variables of HCC.
Yamamoto K; Imamura H; Matsuyama Y; Kume Y; Ikeda H; Norman GL; Shums Z; Aoki T; Hasegawa K; Beck Y; Sugawara Y; Kokudo N
J Gastroenterol; 2010 Dec; 45(12):1272-82. PubMed ID: 20625772
[TBL] [Abstract][Full Text] [Related]
18. [Clinical significance and diagnostic value of Golgi-protein 73 in patients with early-stage primary hepatocellular carcinoma].
Bao YX; Yang Y; Zhao HR; Mao R; Xiao L; Zhang YF; Aisiker T; Wen H
Zhonghua Zhong Liu Za Zhi; 2013 Jul; 35(7):505-8. PubMed ID: 24257301
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic performance of alpha-fetoprotein, lens culinaris agglutinin-reactive alpha-fetoprotein, des-gamma carboxyprothrombin, and glypican-3 for the detection of hepatocellular carcinoma: a systematic review and meta-analysis protocol.
Huang TS; Shyu YC; Turner R; Chen HY; Chen PJ
Syst Rev; 2013 Jun; 2():37. PubMed ID: 23738605
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of individual and combined applications of serum biomarkers for diagnosis of hepatocellular carcinoma: a meta-analysis.
Hu B; Tian X; Sun J; Meng X
Int J Mol Sci; 2013 Dec; 14(12):23559-80. PubMed ID: 24317431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
